BELLBIRD MEDICAL COMMUNICATIONS LIMITEDActive

Company number 12698151Private limited companyIncorporated 2020

Key figures

£305-54.3%
Net assets 2024/25
-71.0%
Average annual change 2020/21–2024/25
020 k40 k60 k80 k2020/212021/222022/232023/242024/25

Like most small UK companies, BELLBIRD MEDICAL COMMUNICATIONS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Total assets61,470190,926140,91447,27756,571
Total liabilities17,484120,129100,19445,56555,366
Net assets / total equity43,18569,93639,676668305
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

74909

As described in the company's latest filed accounts.

Summary: BELLBIRD MEDICAL COMMUNICATIONS LIMITED

Company

BELLBIRD MEDICAL COMMUNICATIONS LIMITED is a private limited company registered with Companies House under company number 12698151. It was incorporated on 25 Jun 2020. Its status is active. The registered office is in Kendal (LA9). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were £305, down 54.3% on the previous year. Total assets were £56,571 and total liabilities £55,366. The company had an average of 2 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 8 Jul 2027.